Click a link below to view the mailing archive as if it had been sent to you.
| 2022-09-30 12:15 | | Illumina Aims to Push Genetics Beyond the Lab With $200 Genome and more... |
| 2022-09-30 00:15 | | FDA approves ALS drug from Amylyx, giving patients a much-needed treatment option and more... |
| 2022-09-29 12:15 | | Medicare Part B premiums to drop 3% next year, partly due to limited Aduhelm coverage and more... |
| 2022-09-29 00:15 | | A bionic pancreas aims to take the math out of managing type 1 diabetes and more... |
| 2022-09-28 12:15 | | Lecanemab can; now the wait for details begins and more... |
| 2022-09-28 00:15 | | First approval of TAAV synthetic DNA material for use in clinical trial and more... |
| 2022-09-27 12:15 | | Biogen pays $900M to settle wide-ranging physician kickback claims and more... |
| 2022-09-27 00:15 | | Prime Medicine becomes the next high-profile biotech to test the IPO waters and more... |
| 2022-09-26 12:15 | | Novartis wins on quantity, but Eli Lilly takes the cake on value of new launches: report and more... |
| 2022-09-26 00:15 | | Moderna seeks FDA nod for Omicron-targeted COVID shot for adolescents, younger kids and more... |
| 2022-09-23 12:15 | | AstraZeneca dumps Ionis drug despite hit in phase 2 cholesterol trial and more... |
| 2022-09-23 00:15 | | FDA panel votes against Spectrum's lung cancer drug and more... |
| 2022-09-22 12:15 | | GSK plays the white knight, paying $66M to rescue Spero's oral antibiotic after FDA rejection and more... |
| 2022-09-22 00:15 | | Facing 'imminent' Gilenya generics and a $300M sales hit, Novartis takes patent fight to Supreme Court and more... |
| 2022-09-21 12:15 | | Orchestra BioMed stays on key in extended study of blood pressure reducing device and more... |
| 2022-09-21 00:15 | | FDA slams Spectrum and Oncopeptides cancer drugs over efficacy concerns ahead of ODAC meeting and more... |
| 2022-09-20 12:15 | | Abbott’s latest Amulet-Watchman data show more mixed results for the heart devices and more... |
| 2022-09-20 00:15 | | Seagen secures a speedy FDA review on Tukysa as Merck buyout talks reportedly stall and more... |
| 2022-09-19 12:15 | | Teva expects to start paying U.S. opioid settlement in 2023 and more... |
| 2022-09-19 00:15 | | AbbVie and BMS slash 360 jobs in California, the latest in a streak of biopharma layoffs and more... |
| 2022-09-16 12:15 | | Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms and more... |
| 2022-09-16 00:15 | | Are biotech SPACs back? Cancer-focused Apollomics next to take blank-check route and more... |
| 2022-09-15 12:15 | | Novartis headquarters raided in Swiss competition authority's patent probe and more... |
| 2022-09-15 00:15 | | Vaccinated people up to 80% less likely to have long COVID-19: study and more... |
| 2022-09-14 12:15 | | Can biotech IPOs bounce back? Third Harmonic to test investor appetite with planned offering and more... |
| 2022-09-14 00:15 | | AbbVie unveils 'See Yourself' Botox campaign, days after new rival approved and more... |
| 2022-09-13 12:15 | | Biden to launch new support for U.S. biotech production and more... |
| 2022-09-13 00:15 | | BioMarin says PhIII gene therapy study participant's cancer is unrelated to therapy and more... |
| 2022-09-12 12:15 | | ESMO: Bristol Myers, Roche fail in post-surgery kidney cancer. But is it good news for Merck's Keytruda? and more... |
| 2022-09-12 00:15 | | Bristol Myers gets FDA approval for new type of psoriasis drug and more... |
| 2022-09-10 00:15 | | ESMO: GSK keeps the faith in anti-TIGIT plans; it's 'not always about being first' and more... |
| 2022-09-09 12:15 | | Merck KGaA continues expansion with $285M+ investment in 2 new projects in France and Germany and more... |
| 2022-09-09 00:15 | | Teva fires back at GSK again over potential 'skinny' label SCOTUS case and more... |
| 2022-09-08 12:15 | | A long Covid collaborative kicks off with $15M to study causes of lingering disease, conduct clinical trials and more... |
| 2022-09-08 00:15 | | ESMO: Gilead's Trodelvy makes surprise comeback with above-par breast cancer survival showing and more... |
| 2022-09-07 12:15 | | Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy and more... |
| 2022-09-07 00:15 | | White House signals most people will only need annual Covid booster and more... |
| 2022-09-06 12:15 | | Medtech takes on pain and more... |
| 2022-09-03 00:15 | | Beyond headlines and amyloid, the Alzheimer's pipeline chugs along and more... |
| 2022-09-02 00:15 | | Pharma groups: FDA is exceeding its authority in risk management plan guidance and more... |
| 2022-09-01 12:15 | | Novo Nordisk to acquire Forma Therapeutics in $1.1. bln deal and more... |
| 2022-09-01 00:15 | | AstraZeneca scores injunction to temporarily halt former exec's start at crosstown rival GSK and more... |
